(Q38810926)

6 September 2017

title

Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers (English)

1 reference

tertiary lymphoid structure

6 September 2017

main subject

1 reference

based on heuristic

inferred from title

author

Marie-Caroline Dieu-Nosjean

1

Marie-Caroline Dieu-Nosjean

0 references

Catherine Sautès-Fridman

6

Catherine Sautès-Fridman

0 references

Wolf Hervé Fridman

5

Wolf Herman Fridman

0 references

Nicolas A Giraldo

Nicolas A Giraldo

2

0 references

author name string

Hélène Kaplon

3

1 reference

6 September 2017

Claire Germain

4

1 reference

6 September 2017

publication date

1 May 2016

1 reference

6 September 2017

published in

Immunological Reviews

1 reference

6 September 2017

volume

271

1 reference

6 September 2017

issue

1

1 reference

6 September 2017

page(s)

260-275

1 reference

The immune contexture in human tumours: impact on clinical outcome

6 September 2017

cites work

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

21 January 2018

1 reference

Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

21 January 2018

1 reference

The immune contexture of primary and metastatic human tumours

21 January 2018

1 reference

Cancer immunotherapy comes of age

21 January 2018

1 reference

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

Tumor microenvironment is multifaceted

21 January 2018

1 reference

Tertiary lymphoid structures in cancer and beyond

21 January 2018

1 reference

Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response

21 January 2018

1 reference

Immune responses elicited in tertiary lymphoid tissues display distinctive features

21 January 2018

1 reference

A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection

21 January 2018

1 reference

Ectopic lymphoid-like structures in infection, cancer and autoimmunity

21 January 2018

1 reference

Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.

21 January 2018

1 reference

Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development.

21 January 2018

1 reference

Cancer-related inflammation

21 January 2018

1 reference

The immune response in cancer: from immunology to pathology to immunotherapy

21 January 2018

1 reference

Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

21 January 2018

1 reference

Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation

21 January 2018

1 reference

Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions

21 January 2018

1 reference

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity

21 January 2018

1 reference

Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza

21 January 2018

1 reference

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells

21 January 2018

1 reference

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

21 January 2018

1 reference

Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer.

21 January 2018

1 reference

In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor

21 January 2018

1 reference

Leukocyte migration in the interstitial space of non-lymphoid organs.

21 January 2018

1 reference

Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis

21 January 2018

1 reference

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

21 January 2018

1 reference

The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients

21 January 2018

1 reference

Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer

21 January 2018

1 reference

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes

21 January 2018

1 reference

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.

21 January 2018

1 reference

HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes

21 January 2018

1 reference

Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice

21 January 2018

1 reference

Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.

21 January 2018

1 reference

A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment

21 January 2018

1 reference

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.

21 January 2018

1 reference

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

21 January 2018

1 reference

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

21 January 2018

1 reference

A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4(+) T cell receptor repertoire clonality

21 January 2018

1 reference

Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma

21 January 2018

1 reference

Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.

21 January 2018

1 reference

Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes

21 January 2018

1 reference

Meta-analysis identifies NF-κB as a therapeutic target in renal cancer

21 January 2018

1 reference

Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.

21 January 2018

1 reference

T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6.

21 January 2018

1 reference

The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer.

21 January 2018

1 reference

The association of CXCR3 and renal cell carcinoma metastasis.

21 January 2018

1 reference

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.

21 January 2018

1 reference

Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting

21 January 2018

1 reference

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.

21 January 2018

1 reference

Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma

21 January 2018

1 reference

Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine

21 January 2018

1 reference

Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.

21 January 2018

1 reference

Human renal cell carcinoma inhibits dendritic cell maturation and functions

21 January 2018

1 reference

From mice to humans: developments in cancer immunoediting

21 January 2018

1 reference

High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma

21 January 2018

1 reference

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

21 January 2018

1 reference

Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells.

21 January 2018

1 reference

The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development

21 January 2018

1 reference

Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules

21 January 2018

1 reference

Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy

21 January 2018

1 reference

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response

21 January 2018

1 reference

New insights into the development of lymphoid tissues

21 January 2018

1 reference

RANK/RANKL/OPG role in distraction osteogenesis

21 January 2018

1 reference

RANK-Fc: a therapeutic antagonist for RANK-L in myeloma

21 January 2018

1 reference

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

21 January 2018

1 reference

IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses

21 January 2018

1 reference

Interleukin-21 inhibits dendritic cell activation and maturation

21 January 2018

1 reference

The role of IL-21 in immunity and cancer

21 January 2018

1 reference

The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells

21 January 2018

1 reference

Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses

21 January 2018

1 reference

Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice

21 January 2018

1 reference

IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism

21 January 2018

1 reference

A fundamental role for interleukin-21 in the generation of T follicular helper cells

21 January 2018

1 reference

Rational design of interleukin-21 antagonist through selective elimination of the gammaC binding epitope

21 January 2018

1 reference

Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS).

21 January 2018

1 reference

ICOS is essential for effective T-helper-cell responses

21 January 2018

1 reference

Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells

21 January 2018

1 reference

ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.

21 January 2018

1 reference

Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells

21 January 2018

1 reference

Targeting costimulatory molecules to improve antitumor immunity.

21 January 2018

1 reference

Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison.

21 January 2018

1 reference

The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes.

21 January 2018

1 reference

Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells.

21 January 2018

1 reference

Crucial roles of interleukin-7 in the development of T follicular helper cells and in the induction of humoral immunity

21 January 2018

1 reference

Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function

21 January 2018

1 reference

Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis

21 January 2018

1 reference

Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition

21 January 2018

1 reference

Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression

21 January 2018

1 reference

Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis

21 January 2018

1 reference

IL-7 modulates in vitro and in vivo human memory T regulatory cell functions through the CD39/ATP axis.

21 January 2018

1 reference

IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells.

21 January 2018

1 reference

Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice

21 January 2018

1 reference

Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis.

21 January 2018

1 reference

Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation

21 January 2018

1 reference

The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes

21 January 2018

1 reference

CXCL13 antibody for the treatment of autoimmune disorders

21 January 2018

1 reference

Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease

21 January 2018

1 reference

Inhibition of generation of cytotoxic T lymphocyte activity by a CCL19/macrophage inflammatory protein (MIP)-3beta antagonist

21 January 2018

1 reference

CCL21 Cancer Immunotherapy

21 January 2018

1 reference

A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model

21 January 2018

1 reference

Local expression of secondary lymphoid tissue chemokine delivered by adeno-associated virus within the tumor bed stimulates strong anti-liver tumor immunity

21 January 2018

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.

21 January 2018

1 reference

Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma

21 January 2018

1 reference

Manifestation of spontaneous and early autoimmune gastritis in CCR7-deficient mice

21 January 2018

1 reference

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

21 January 2018

1 reference

Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity

21 January 2018

1 reference

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

21 January 2018

1 reference

Regulation of tumor-associated high-endothelial venules by dendritic cells: A new opportunity to promote lymphocyte infiltration into breast cancer?

21 January 2018

1 reference

Characteristics and significance of colorectal cancer associated lymphoid reaction

21 January 2018

1 reference

Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers

21 January 2018

1 reference

Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling

21 January 2018

1 reference

Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients

21 January 2018

1 reference

12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

21 January 2018

1 reference

Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma

21 January 2018

1 reference

Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer

21 January 2018

1 reference

B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IMR.12405

1 reference

6 September 2017

1 reference